Can we stop giving preventive antibiotics to transplant patients?
NCT ID NCT07308457
Summary
This study aims to find out if closely watching for signs of infection works as well as giving daily preventive antibiotics to adults receiving stem cell transplants for blood cancers. Researchers will compare two groups: one that gets a daily antibiotic (ceftriaxone) and one that does not, but is monitored with continuous temperature checks and prompt testing. The goal is to see which approach better prevents serious infections, especially in hospitals where bacteria are becoming resistant to common drugs.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INCIDENCE OF INFECTIOUS DISEASES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Uniwersytecki zpital Kliniczny nr 1 im. prof. Tadeusza Sokołowskiego Pomorskiego Uniwersytetu Medycznego w Szczecinie
RECRUITINGSzczecin, West Pomeranian Voivodeship, 71-252, Poland
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.